Johnson Charles A 4
4 · INSPIRE PHARMACEUTICALS INC · Filed Sep 17, 2010
Insider Transaction Report
Form 4
Johnson Charles A
EVP of R&D & Chief Med. Ofcr.
Transactions
- Award
Restricted Stock Unit
2010-09-15−150,000→ 150,000 total→ Common Stock (150,000 underlying) - Award
Stock Option (Right to Buy)
2010-09-15−250,000→ 250,000 totalExercise: $5.11Exp: 2017-09-14→ Common Stock (250,000 underlying)
Footnotes (3)
- [F1]Shall vest over 4 years as follows: 25% on the first anniversary on which the executive's employment with the Company commences, and thereafter in thirty-six (36) monthly installments after the first anniversary of the date of employment until fully vested.
- [F2]Each Restricted Stock Unit represents a contingent right to receive one share of the common stock of Inspire Pharmaceuticals, Inc. The shares will be delivered following the end of the scheduled vesting date or 60 days following an earlier vesting date that occurs as a result of the grantee's separation from service.
- [F3]Vests as follows: 25% percent as of the first anniversary of the effective date of the executive's employment and the remainder shall then vest ratably on an annual basis over the next three years on the respective anniversary dates of the effective date of the executive's employment until fully vested.